Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Kerr

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Research in Veterinary Science|January 1, 1978
Pharmacokinetics and dosage of oxytetracycline in dogsJ D Baggot, T E Powers, J D Powers, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 1, 1997
p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinomaM MacKinnon, K M Kerr, G King, et al.
The Journal of Pathology|December 13, 2000
Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinomaS Ramasami, K M Kerr, A D Chapman, et al.
QJM : Monthly Journal of the Association of Physicians|March 15, 2013
A rare cause of pleural diseaseH Haja Mydin, G P Currie, A R Denison, et al.
The Journal of the Royal College of Physicians of Edinburgh|July 17, 2015
Survival from malignant mesothelioma: where are we now?A D Marshall, H K Bayes, J Bardgett, et al.
QJM : Monthly Journal of the Association of Physicians|March 8, 2012
Endobronchial ultrasound transbronchial needle aspiration at Aberdeen Royal Infirmary: the initial experienceD Miller, P Mahendra, V Bruce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2015
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upP Baas, D Fennell, K M Kerr, et al.
Journal of Clinical Pathology|August 29, 2000
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell categoryS L Edwards, C Roberts, M E McKean, et al.
The Journal of Pathology|April 1, 1997
The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lungC A Cooper, F A Carby, V J Bubb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2017
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upJ B A G Haanen, F Carbonnel, C Robert, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Research in Veterinary Science|January 1, 1978
Pharmacokinetics and dosage of oxytetracycline in dogsJ D Baggot, T E Powers, J D Powers, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 1, 1997
p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinomaM MacKinnon, K M Kerr, G King, et al.
The Journal of Pathology|December 13, 2000
Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinomaS Ramasami, K M Kerr, A D Chapman, et al.
QJM : Monthly Journal of the Association of Physicians|March 15, 2013
A rare cause of pleural diseaseH Haja Mydin, G P Currie, A R Denison, et al.
The Journal of the Royal College of Physicians of Edinburgh|July 17, 2015
Survival from malignant mesothelioma: where are we now?A D Marshall, H K Bayes, J Bardgett, et al.
QJM : Monthly Journal of the Association of Physicians|March 8, 2012
Endobronchial ultrasound transbronchial needle aspiration at Aberdeen Royal Infirmary: the initial experienceD Miller, P Mahendra, V Bruce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2015
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upP Baas, D Fennell, K M Kerr, et al.
Journal of Clinical Pathology|August 29, 2000
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell categoryS L Edwards, C Roberts, M E McKean, et al.
The Journal of Pathology|April 1, 1997
The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lungC A Cooper, F A Carby, V J Bubb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2017
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upJ B A G Haanen, F Carbonnel, C Robert, et al.
Pageof 13